HIV-1 reverse transcription

Methods in Molecular Biology

Volumn 1087, Issue , 2014, Pages 55-70

  Cimarelli, Andrea ^a   Darlix, Jean Luc ^b  

^a UNIVERSITÉ LYON 1   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

HIV 1; Kinetics; Nucleocapsid protein; Reverse transcriptase; Viral DNA synthesis

Indexed keywords

ANTIRETROVIRUS AGENT; NEVIRAPINE; NUCLEOCAPSID PROTEIN; ZIDOVUDINE;

ANIMAL CELL; ARTICLE; CIRCULATING RECOMBINANT FORM; CONTROLLED STUDY; DNA SYNTHESIS; DRUG INHIBITION; EX VIVO STUDY; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION; VIRUS RECOMBINANT; VIRUS STRAIN; VIRUS TRANSMISSION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

DNA, VIRAL; DRUG RESISTANCE, VIRAL; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HEK293 CELLS; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; REVERSE TRANSCRIPTION; RNA, VIRAL;

EID: 84934442898     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-670-2_6     Document Type: Article

References (57)

1. Baltimore D (1970) RNA-dependent DNA polymerase in virions of RNA tumour viruses. Nature 226:1209-1211
2. Gilboa E, Mitra SW, Goff S, Baltimore D (1979) A detailed model of reverse transcription and tests of crucial aspects. Cell 18:93-100
3. Coffi n JM (1990) Retroviridae and their replication. In: Fields BN, Knipe DM et al. (eds.) Virology, 2nd edn. Raven Press Ltd, New York, p 1437-1500
4. Coffi n JM (1979) Structure, replication, and recombination of retrovirus genomes: some unifying hypotheses. J Gen Virol 42:1-26
5. Mougel M, Houzet L, Darlix JL (2009) When is it time for reverse transcription to start and go? Retrovirology 6:24
6. Temin HM, Mizutani S (1970) RNAdependent DNA polymerase in virions of Rous sarcoma virus. Nature 226:1211-1213
7. Mizutani S, Boettiger D, Temin HM (1970) A DNA-dependent DNA polymerase and a DNA endonuclease in virions of Rous sarcoma virus. Nature 228:424-427
8. Delelis O, Carayon K, Saib A, Deprez E, Mouscadet JF (2008) Integrase and integration: biochemical activities of HIV-1 integrase. Retrovirology 5:114
9. Lewinski MK, Bushman FD (2005) Retroviral DNA integration-mechanism and consequences. Adv Genet 55:147-181
10. Chen J, Nikolaitchik O, Singh J, Wright A, Bencsics CE, Coffi n JM, Ni N, Lockett S, Pathak VK, Hu WS (2009) High effi ciency of HIV-1 genomic RNA packaging and heterozygote formation revealed by single virion analysis. Proc Natl Acad Sci USA 106:13535-13540
11. Chertova E, Chertov O, Coren LV, Roser JD, Trubey CM, Bess JW Jr, Sowder RC 2nd, Barsov E, Hood BL, Fisher RJ et al (2006) Proteomic and biochemical analysis of purifi ed human immunodefi ciency virus type 1 produced from infected monocyte-derived macrophages. J Virol 80:9039-9052
12. Darlix JL, Garrido JL, Morellet N, Mely Y, de Rocquigny H (2007) Properties, functions, and drug targeting of the multifunctional nucleocapsid protein of the human immunodefi ciency virus. Adv Pharmacol 55:299-346
13. Darlix JL, Lapadat-Tapolsky M, de Rocquigny H, Roques BP (1995) First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses. J Mol Biol 254:523-537
14. Iordanskiy SN, Bukrinsky MI (2009) Analysis of viral and cellular proteins in HIV-1 reverse transcription complexes by co-immunoprecipitation. Methods Mol Biol 485:121-134
15. Levin JG, Guo J, Rouzina I, Musier-Forsyth K (2005) Nucleic acid chaperone activity of HIV-1 nucleocapsid protein: critical role in reverse transcription and molecular mechanism. Prog Nucleic Acid Res Mol Biol 80: 217-286
16. Rein A, Henderson LE, Levin JG (1998) Nucleic-acid-chaperone activity of retroviral nucleocapsid proteins: signifi cance for viral replication. Trends Biochem Sci 23:297-301
17. Berkhout B (1996) Structure and function of the human immunodefi ciency virus leader RNA. Prog Nucleic Acid Res Mol Biol 54: 1-34
18. Kleiman L, Halwani R, Javanbakht H (2004) The selective packaging and annealing of primer tRNALys3 in HIV-1. Curr HIV Res 2:163-175
19. Molling K, Bolognesi DP, Bauer H, Busen W, Plassmann HW, Hausen P (1971) Association of viral reverse transcriptase with an enzyme degrading the RNA moiety of RNA-DNA hybrids. Nat New Biol 234:240-243
20. Lener D, Tanchou V, Roques BP, Le Grice SF, Darlix JL (1998) Involvement of HIV-I nucleocapsid protein in the recruitment of reverse transcriptase into nucleoprotein complexes formed in vitro. J Biol Chem 273: 33781-33786
21. Abbondanzieri EA, Bokinsky G, Rausch JW, Zhang JX, Le Grice SF, Zhuang X (2008) Dynamic binding orientations direct activity of HIV reverse transcriptase. Nature 453: 184-189
22. Holmes RK, Malim MH, Bishop KN (2007) APOBEC-mediated viral restriction: not simply editing? Trends Biochem Sci 32(3):118-128
23. Yan N, Regalado-Magdos AD, Stiggelbout B, Lee-Kirsch MA, Lieberman J (2010) The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodefi ciency virus type 1. Nat Immunol 11(11):1005-1013
24. Allain B, Lapadat TM, Berlioz C, Darlix JL (1994) Transactivation of the minus-strand DNA transfer by nucleocapsid protein during reverse transcription of the retroviral genome. EMBO J 13:973-981
25. Tsuchihashi Z, Brown PO (1994) DNA strand exchange and selective DNA annealing promoted by the human immunodefi ciency virus type 1 nucleocapsid protein. J Virol 68:5863-5870
26. Godet J, de Rocquigny H, Raja C, Glasser N, Ficheux D, Darlix JL, Mely Y (2006) During the early phase of HIV-1 DNA synthesis, nucleocapsid protein directs hybridization of the TAR complementary sequences via the ends of their double-stranded stem. J Mol Biol 356:1180-1192
27. Auxilien S, Keith G, Le Grice SF, Darlix JL (1999) Role of post-transcriptional modifi cations of primer tRNALys,3 in the fi delity and effi cacy of plus strand DNA transfer during HIV-1 reverse transcription. J Biol Chem 274:4412-4420
28. Ramalanjaona N, de Rocquigny H, Millet A, Ficheux D, Darlix JL, Mely Y (2007) Investigating the mechanism of the nucleocapsid protein chaperoning of the second strand transfer during HIV-1 DNA synthesis. J Mol Biol 374:1041-1053
29. Darlix JL, Vincent A, Gabus C, de Rocquigny H, Roques B (1993) Trans-activation of the 5? to 3? viral DNA strand transfer by nucleocapsid protein during reverse transcription of HIV1 RNA. C R Acad Sci III 316(8):763-771
30. Darlix JL, Godet J, Ivanyi-Nagy R, Fossé P, Mauffret O, Mély Y (2011) Flexible nature and specifi c functions of the HIV-1 nucleocapsid protein. J Mol Biol 410(4):565-581
31. Kleiman L (2002) tRNA(Lys3): the primer tRNA for reverse transcription in HIV-1. IUBMB Life 53:107-114
32. Klarmann GJ, Hawkins ME, Le Grice SF (2002) Uncovering the complexities of retroviral ribonuclease H reveals its potential as a therapeutic target. AIDS Rev 4:183-194
33. Bampi C, Bibillo A, Wendeler M, Divita G, Gorelick RJ, Le Grice SF, Darlix JL (2006) Nucleotide excision repair and templateindependent addition by HIV-1 reverse transcriptase in the presence of nucleocapsid protein. J Biol Chem 281(17):11736-11743
34. Buckman JS, Bosche WJ, Gorelick RJ (2003) Human immunodefi ciency virus type 1 nucleocapsid zn(2+) fi ngers are required for effi cient reverse transcription, initial integration processes, and protection of newly synthesized viral DNA. J Virol 77:1469-1480
35. Carteau S, Gorelick RJ, Bushman FD (1999) Coupled integration of human immunodefi-ciency virus type 1 cDNA ends by purifi ed integrase in vitro: stimulation by the viral nucleocapsid protein. J Virol 73:6670-6679
36. Ciuffi A, Bushman FD (2006) Retroviral DNA integration: HIV and the role of LEDGF/p75. Trends Genet 22:388-395
37. Ciuffi A, Llano M, Poeschla E, Hoffmann C, Leipzig J, Shinn P, Ecker JR, Bushman F (2005) A role for LEDGF/p75 in targeting HIV DNA integration. Nat Med 11:1287-1289
38. Di Santo R, Costi R, Roux A, Miele G, Crucitti GC, Iacovo A, Rosi F, Lavecchia A, Marinelli L, Di Giovanni C et al (2008) Novel quinolinonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, and biological activities. J Med Chem 51:4744-4750
39. Cimarelli A, Darlix JL (2002) Assembling the human immunodefi ciency virus type 1. Cell Mol Life Sci 59:1166-1184
40. Lori F, di Marzo Veronese F, de Vico AL, Lusso P, Reitz MS Jr, Gallo RC (1992) Viral DNA carried by human immunodefi ciency virus type 1 virions. J Virol 66:5067-5074
41. Trono D (1992) Partial reverse transcripts in virions from human immunodefi ciency and murine leukemia viruses. J Virol 66:4893-4900
42. Houzet L, Morichaud Z, Didierlaurent L, Muriaux D, Darlix JL, Mougel M (2008) Nucleocapsid mutations turn HIV-1 into a DNA-containing virus. Nucleic Acids Res 36:2311-2319
43. Thomas JA, Bosche WJ, Shatzer TL, Johnson DG, Gorelick RJ (2008) Mutations in human immunodefi ciency virus type 1 nucleocapsid protein zinc fi ngers cause premature reverse transcription. J Virol 82:9318-9328
44. Zhang H, Dornadula G, Pomerantz RJ (1996) Endogenous reverse transcription of human immunodefi ciency virus type 1 in physiological microenvironments: an important stage for viral infection of nondividing cells. J Virol 70:2809-2824
45. Munch J, Rucker E, Standker L, Adermann K, Goffi net C, Schindler M, Wildum S, Chinnadurai R, Rajan D, Specht A et al (2007) Semen-derived amyloid fi brils drastically enhance HIV infection. Cell 131:1059-1071
46. Roan NR, Greene WC (2007) A seminal fi nding for understanding HIV transmission. Cell 131:1044-1046
47. D'Souza V, Summers MF (2005) How retroviruses select their genomes. Nat Rev Microbiol 3:643-655
48. Onafuwa-Nuga A, Telesnitsky A (2009) The remarkable frequency of human immunodefi-ciency virus type 1 genetic recombination. Microbiol Mol Biol Rev 73:451-480
49. Zhang M, Foley B, Schultz AK, Macke JP, Bulla I, Stanke M, Morgenstern B, Korber B, Leitner T (2010) The role of recombination in the emergence of a complex and dynamic HIV epidemic. Retrovirology 7:25
50. Bocharov G, Ford NJ, Edwards J, Breinig T, Wain-Hobson S, Meyerhans A (2005) A genetic-algorithm approach to simulating human immunodefi ciency virus evolution reveals the strong impact of multiply infected cells and recombination. J Gen Virol 86: 3109-3118
51. Baird HA, Gao Y, Galetto R, Lalonde M, Anthony RM, Giacomoni V, Abreha M, Destefano JJ, Negroni M, Arts EJ (2006) Infl uence of sequence identity and unique breakpoints on the frequency of intersubtype HIV-1 recombination. Retrovirology 3:91
52. Hu WS, Temin HM (1990) Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination. Proc Natl Acad Sci USA 87:1556-1560
53. Strebel K, Khan MA (2008) APOBEC3G encapsidation into HIV-1 virions: which RNA is it? Retrovirology 5:55
54. Malim MH (2009) APOBEC proteins and intrinsic resistance to HIV-1 infection. Philos Trans R Soc Lond B Biol Sci 364(1517): 675-687
55. Arfi V, Lienard J, Nguyen XN, Berger G, Rigal D, Darlix JL, Cimarelli A (2009) Characterization of the behavior of functional viral genomes during the early steps of human immunodefi ciency virus type 1 infection. J Virol 83:7524-7535
56. Mbisa JL, Delviks-Frankenberry KA, Thomas JA, Gorelick RJ, Pathak VK (2009) Real-time PCR analysis of HIV-1 replication post-entry events. Methods Mol Biol 485:55-72
57. HIV drug resistant mutations by drug class. Stanford HIV Drug resistance database. Analyze sequence sets for proportions with Surveillance Drug Resistance Mutations (SDRMs). http://hivdb.stanford.edu (USA)